Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

  

EXHIBIT I

 

JOINT FILING AGREEMENT

 

This will confirm the agreement by and among the undersigned that the Schedule 13G filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the Common Stock, par value $0.01 per share, of Enanta Pharmaceuticals, Inc. will be filed on behalf of each of the persons and entities named below in accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

 

Dated: January 21, 2025

 

	INTEGRATED CORE STRATEGIES (US) LLC   By: Integrated Holding Group LP, its Managing Member   By: Millennium Management LLC, its General Partner   By: /s/ Gil Raviv                                          Name: Gil Raviv Title: Global General Counsel     MILLENNIUM MANAGEMENT LLC   By: /s/ Gil Raviv                                          Name: Gil Raviv Title: Global General Counsel
	MILLENNIUM GROUP MANAGEMENT LLC   By: /s/ Gil Raviv                                          Name: Gil Raviv Title: Global General Counsel     /s/ Israel A. Englander                                 Israel A. Englander

   

 

---